Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
OncXerna Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
OncXerna Therapeutics

OncXerna Therapeutics

Series C

Oncologie Ltd., a China-based precision medicine provider, manufactures innovative biotech products.

HQ
Waltham, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

OncXerna Therapeutics, originally founded as Oncologie Ltd. in China, is a precision medicine provider focused on developing innovative biotechnology products. The company's core mission is to harness the power of RNA-based biomarkers to create targeted cancer therapies, aiming to improve patient outcomes through personalized medicine. OncXerna offers novel pharmaceuticals and drug substances designed to address unmet medical needs in oncology, with a market focus on delivering precision treatments for cancer patients worldwide.

Notable affiliated individuals include industry experts and seasoned professionals in biotechnology and oncology. The company has garnered significant investment from leading venture capital firms specializing in life sciences. Key achievements include the development of proprietary RNA-based biomarker platforms and successful clinical trials demonstrating the efficacy of their targeted therapies. OncXerna's impact lies in its contribution to the advancement of precision oncology, offering hope for more effective and personalized cancer treatments.

OncXerna Therapeutics - Similar Companies

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Xsphera Biosciences logo

Xsphera Biosciences

Oncolix logo

Oncolix

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

Orna Therapeutics logo

Orna Therapeutics

OncoSpherix logo

OncoSpherix

oncospherix.com

xCures logo

xCures

xcures.com

Cullinan Oncology logo

Cullinan Oncology

OncoSenX logo

OncoSenX

oncosenx.com

OncoResponse logo

OncoResponse

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Alphina Therapeutics logo

Alphina Therapeutics

Ochre Bio logo

Ochre Bio

ochre-bio.com

CytomX Therapeutics logo

CytomX Therapeutics

cytomx.com

Exai Bio logo

Exai Bio

exai.bio

OncXerna Therapeutics - Quick Facts

Who are OncXerna Therapeutics' competitors?

Companies similar to OncXerna Therapeutics include OncoPrecision, Xsphera Biosciences, Oncolix and OnCusp Therapeutics.

When was OncXerna Therapeutics founded?

OncXerna Therapeutics was founded in 2018.

Where is OncXerna Therapeutics' headquarters located?

OncXerna Therapeutics' headquarters is located in Waltham, MA, US.

When was OncXerna Therapeutics' last funding round?

OncXerna Therapeutics' most recent funding round was for $30M (USD) in March 2022.

How much has OncXerna Therapeutics raised to-date?

As of Mar 3, 2022, OncXerna Therapeutics has raised a total of $126.5M (USD).

How many employees does OncXerna Therapeutics have?

OncXerna Therapeutics has 11 employees as of Feb 5, 2024.

OncXerna Therapeutics - Classification

Industry
  • Biotechnology
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotechnology
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified